Israel-based healthcare-dedicated VC with $1.2B under management, investing in breakthrough life sciences innovations at all development stages. Track record of 24 IPOs and 19 acquisitions.
Auto-detected from Pontifax's website.
Joined Pontifax in 2007 with 15+ years managing finances and operations at Israeli and multinational VC firms.
Principal involved in identifying and evaluating opportunities with PhD in glycosylation and postdoctoral research in Tuberculosis persistence.
Joined Pontifax in 2018 with 16+ years managing venture debt funds and 100+ debt transactions in mid to late-stage companies.
Joined Pontifax in 2009, involved in identifying and evaluating new investment opportunities with M.S. in Biology.
Co-founder and managing partner overseeing 65+ portfolio companies globally with extensive pharma board experience including Kite Pharma, cCAM, and ArQule.
Co-founder and CEO of Pontifax with 10+ years in senior management at Israeli financial institutions investing in technology-driven startups.
Focus and check size from the firm's website. Website reachable as of Aug 2026.
A fit check scores your pitch against their thesis, stage and ticket. An email draft uses their real deals and thesis, not a template.